Phathom Pharmaceuticals, Inc.

Brevan Howard Capital Management LP PHAT

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

276,989

Value ($000)

4,595

Weight

0.1%

2024 Q2 - 2025 Q4 (5 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	4,595	0.1%	276,989	12/31/2025
2025 Q3	11/14/2025	684	0.0%	58,097	9/30/2025
2025 Q2	8/14/2025	267	0.0%	27,834	6/30/2025
2024 Q4	2/14/2025	186	0.0%	22,845	12/31/2024
2024 Q2	8/14/2024	194	0.0%	18,792	6/30/2024